Early last week, the US Food and Drug Administration (FDA) announced their addition of warning labels on statins, a group of cholesterol lowering drugs. The action comes on the heels of the agency’s review of medical literature, clinical trial data, and reports of adverse events leading to increased levels of blood sugar and potential memory loss.

» Continue Reading

Related terms:

• crestor study of nearly 18 000 patients
• FDA The value of statins in preventing heart disease has been clearly established Amy Egan deputy director for safety in FDAs Division of Metabolism and Endocrinology Products said in a statement Their benefit is indisputable but they need to be taken wi
• Lava statin
• lava statin side effects
• ortiga PILLS
• statins can raise the risk of diabetes by 9 percent
• statins memory loss study